All tagged iGEM Community

In Conversation with Eric Herrera, CEO - Maverick Biometals | Interviews with Biofounders: From a Baltimore Bench to a 10,000 sq. ft. biotech lab - Maverick BioMetals is Pioneering BioMining Solutions

Meet Eric Herrera, the co-founder and CEO of Maverick Biometals, a finalist in the 2022 iGEM Startup Showcase in 2022 and Y Combinator S22 Cohort. Eric shared his remarkable entrepreneurship journey, starting with a single bench in a Baltimore basement to a 10,000 sq. ft. biotechnology laboratory. With a team of scientists from over 10 countries, Maverick Biometals is pioneering the production of lithium batteries and silicon semiconductors entirely through biological methods

2024 Insights: iGEM Alumni Startups Funding Trends and SynBio x AI Innovations

2024 has been an incredible year for iGEM Startups, marked by notable funding trends among iGEM Alumni startups, particularly at the intersection of artificial intelligence (AI) and synthetic biology (SynBio) within our ecosystem. This year alone, seven alumni startups have secured over $95 million in funding—from government grants to multimillion-dollar investments—highlighting the scalability and market potential of these groundbreaking technologies.

In Conversation with the Co-Founder of Granza Bio — From Lab Partners to Biofounders: How a Chance Collaboration Built Granza Bio

Ashwin Jainarayanan is a biofounder with a deep-rooted passion for advancing medical science through synthetic biology and immuno-oncology. Ashwin's journey of founding Granza Bio began during his PhD at the University of Oxford, when a serendipitous email mix-up connected him with Ashwin Nandakumar, who was working on another project at a nearby department. 

Phoenix’s View: Diagnostic and Therapeutic Solutions from iGEM Teams for Neurodegenerative Diseases

Neurodegenerative diseases comprise a broad spectrum of disorders resulting from the gradual deterioration of cells and connections within the nervous system, crucial for functions such as movement, coordination, strength, sensation, and cognition. Explore how iGEM team’s have tackled the disease through their innovative diagnostic and therapeutic solutions.